|
Bethesda, MD - Innovative Neurotronics, Inc. (IN, Inc.) has been selected as one of
"50 Companies to Watch" by Medical Device and Diagnostic Industry magazine (MD&DI).
The article appears as this month's cover story and is available at:
http://www.devicelink.com/mddi/archive/06/06/002.html.
"We selected 50 companies on the basis of their contributions to the medical
device and healthcare industries," said John Bethune, vice president and editorial
director for Canon Communications LLC, the publisher of MD&DI. "The companies
reflect outstanding achievements behind today's medical technology."
The medical device industry is well known for its technology, a central
aspect that MD&DI covers in every issue. The June issue marks the first time
MD&DI examines 50 companies that embody the regulatory, technological, and
business know-how to be successful.
"We are honored to be included in a list with so many prestigious, established
organizations," IN, Inc. President Jeff Martin said. "Innovative Neurotronics
was founded to fulfill an unmet need - the restoration of function in those with
an impaired limb. Before we developed Myo-Orthotics Technology, the main option
for a patient with an impaired limb was simply to stabilize that limb, but we
knew more could be done. And so we developed a medical device that actually
empowers the patient."
Cleared for marketing by the FDA in September 2005 and officially launched on
May 1, 2006, IN, Inc.'s first product, the WalkAideŽ System, combats a form of
paralysis known as "foot drop" due to stroke, spinal cord injury, traumatic brain
injury, and other pathologies such as multiple sclerosis and cerebral palsy.
The WalkAide System, which includes diagnosis, treatment modalities, and delivery
of an electrical stimulation device by a trained medical practitioner, treats
foot drop by applying low level electrical currents directly to a motor nerve in
the leg which instructs the muscle to flex the foot so the patient can walk
normally. Contrary to traditional therapies that require the patient to spend
hours in hospitals or rehabilitation facilities, the portable WalkAide also has
an exercise mode that allows the patient to conduct muscle therapy at home.
Worn around the leg, just below the knee, the AA battery-operated device is
about the size of a deck of cards.
Currently available nationwide to patients through certified orthotists at
Hanger Prosthetics and Orthotics, IN, Inc. plans to expand availability of
the WalkAide through other rehabilitation specialists later this year.
About Innovative Neurotronics, Inc.: Specializing in the field of functional
electrical stimulation, Innovative Neurotronics, Inc. identifies emerging
Myo-Orthotics Technologies"! developed at research centers and universities throughout
the world that use neuromuscular stimulation to improve the functionality of an
impaired limb. Innovative Neurotronics, Inc. is a wholly owned subsidiary
of Hanger Orthopedic Group, Inc. (NYSE:HGR), the world's largest provider
of orthotic and prosthetic (O&P) patient care. Headquartered in Bethesda,
Maryland, Hanger owns and operates 621 patient care centers in 46 states
including the District of Columbia, with 3,313 employees including 1,032
practitioners (as of 3/31/06). For more information on Innovative
Neurotronics, Inc, visit http://www.ininc.us.
For more information on Hanger, visit http://www.hanger.com.
Certain statements included in this press release are forward looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Please refer to the Company's SEC filings for factors that could
cause actual results to differ materially from the Company's expectations.
|